Royalty Pharma Plc · NASDAQ:RPRX
Hite Christopher sold 130,000 Royalty Pharma Plc shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Hite Christopher (EVP & Chairman, Partnering) sold 130,000 Royalty Pharma Plc shares at an average US$56.50 for US$7.35M under a trading plan, leaving 40,000 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 130,000 shares
- Price
- US$56.50 average (US$56.44 to US$57.10)
- Value
- US$7.35M
- Holding after
- 40,000 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP & Chairman, Partnering
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Class A Ordinary Shares | Sale | 97,446 | US$56.50 | 461,953 | Indirect |
| Jun 30, 2026 | Class A Ordinary Shares | Sale | 2,554 | US$57.10 | 459,399 | Indirect |
| Jun 30, 2026 | Class A Ordinary Shares | Sale | 29,400 | US$56.44 | 40,600 | Direct |
| Jun 30, 2026 | Class A Ordinary Shares | Sale | 600 | US$57.09 | 40,000 | Direct |
Source
Related
- Royalty Pharma Plc
- Hite Christopher
- Royalty Pharma Plc shareholders
- Form 4 · Hite Christopher · Sep 24, 2026
- Form 4 · Hite Christopher · Aug 19, 2026
- Form 4 · Hite Christopher · Aug 7, 2026
- Form 4 · Hite Christopher · Jun 25, 2026
- Form 4 · Hite Christopher · May 8, 2026
- Form 4 · Urist Marshall · Oct 5, 2026
- Form 4 · Bassler Bonnie L · Sep 30, 2026
- Form 4 · Urist Marshall · Sep 30, 2026
- Form 4 · Coyne Terrance P. · Aug 17, 2026
- Form 4 · Legorreta Pablo G. · Aug 7, 2026